Alexza Pharmaceuticals has announced the appointment of J. Kevin Buchi to its board of directors. Buchi, who was Corporate Vice President, Global Branded Products at Teva Pharmaceutical Industries from October 2011 until May 2012, has over 30 years of experience in the pharmaceutical industry.
Company President and CEO Thomas B. King commented, “We are very pleased to welcome Kevin to our Board of Directors. This will be a transitional year for us, as we move from a development-stage company to a commercial company with the launch of Adasuve. Kevin brings a wealth of experience and expertise to our Board, particularly in product commercialization, partnering and overall corporate development. We look forward to his contributions to Alexza’s next phase.”
Read the Alexza press release.
